Scholarlink

<p><b>Objective.</b> To analyze the frequency of new-onset sleep disorders after infection with the novel coronavirus (COVID-19) in patients with primary headache disorders. <b>Materials and methods.</b> A prospective case-control study was conducted from May 2022 to July 2024 using semi-structured interviews in 212 patients with primary headache disorders and complaints of sleep problems with histories of COVID-19 (study group, <i>n</i> = 135, 98% women, mean age 46.3 years) and without histories of COVID-19 (control group, <i>n</i> = 77, 54% women, mean age 45.7 years). COVID-19 was confirmed by polymerase chain reaction (PCR). Patients in both groups were included in a parallel study in accordance with the inclusion and exclusion criteria. The period from the onset of COVID-19 to the interview was ≥12 months in 57.7% of patients, 6–12 months in 20.1%, and less than six months in 22.2%. The majority (87%) of patients had a mild form of COVID-19. <b>Results.</b> Among patients with primary headaches, pre-existing sleep disorders (before the COVID-19 pandemic period, before 2020) were found in 56.3% with histories of COVID-19 and 59.7% of those without histories of COVID-19. In 39 (28.8%) of 135 patients with histories of COVID-19, sleep disorders occurred for the first time at the onset of COVID-19 and persisted to the time of the interview (at least six months): 25 (18.5%) had chronic insomnia, five (3.7%) had restless legs syndrome, seven (5.2%) had hypersomnia, and two (1.5%) had obstructive sleep apnea syndrome. Sleep disturbances in these patients were not associated with anxiety, depression, other diseases, or use of medication, but were closely related in time of onset to COVID-19. <b>Conclusions.</b> This study showed that one in three patients with primary headaches experience new-onset sleep disturbances associated with COVID-19, which persist for long periods after recovery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sleep Disorders after COVID-19 in Patients with Primary Headache Disorders

  • 期刊论文

  • 发表日期：

    2026年1月26日

查看全文
  • E. A. Tveritin,
  • D. A. Konovalova,
  • D. V. Khamzin,
  • M. L. Chigareva,
  • E. A. Sizikova,
  • E. A. Deriglazova,
  • A. E. Ryazanova,
  • D. V. Gilev,
  • M. G. Poluektov,
  • E. R. Lebedeva

摘要

Objective. To analyze the frequency of new-onset sleep disorders after infection with the novel coronavirus (COVID-19) in patients with primary headache disorders. Materials and methods. A prospective case-control study was conducted from May 2022 to July 2024 using semi-structured interviews in 212 patients with primary headache disorders and complaints of sleep problems with histories of COVID-19 (study group, n = 135, 98% women, mean age 46.3 years) and without histories of COVID-19 (control group, n = 77, 54% women, mean age 45.7 years). COVID-19 was confirmed by polymerase chain reaction (PCR). Patients in both groups were included in a parallel study in accordance with the inclusion and exclusion criteria. The period from the onset of COVID-19 to the interview was ≥12 months in 57.7% of patients, 6–12 months in 20.1%, and less than six months in 22.2%. The majority (87%) of patients had a mild form of COVID-19. Results. Among patients with primary headaches, pre-existing sleep disorders (before the COVID-19 pandemic period, before 2020) were found in 56.3% with histories of COVID-19 and 59.7% of those without histories of COVID-19. In 39 (28.8%) of 135 patients with histories of COVID-19, sleep disorders occurred for the first time at the onset of COVID-19 and persisted to the time of the interview (at least six months): 25 (18.5%) had chronic insomnia, five (3.7%) had restless legs syndrome, seven (5.2%) had hypersomnia, and two (1.5%) had obstructive sleep apnea syndrome. Sleep disturbances in these patients were not associated with anxiety, depression, other diseases, or use of medication, but were closely related in time of onset to COVID-19. Conclusions. This study showed that one in three patients with primary headaches experience new-onset sleep disturbances associated with COVID-19, which persist for long periods after recovery.